These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 8630050)
1. Role of c-jun in the inhibition of erythropoietin receptor-mediated apoptosis. Shimizu R; Komatsu N; Nakamura Y; Nakauchi H; Nakabeppu Y; Miura Y Biochem Biophys Res Commun; 1996 May; 222(1):1-6. PubMed ID: 8630050 [TBL] [Abstract][Full Text] [Related]
2. BCR-ABL and constitutively active erythropoietin receptor (cEpoR) activate distinct mechanisms for growth factor-independence and inhibition of apoptosis in Ba/F3 cell line. Ahmed M; Dusanter-Fourt I; Bernard M; Mayeux P; Hawley RG; Bennardo T; Novault S; Bonnet ML; Gisselbrecht S; Varet B; Turhan AG Oncogene; 1998 Jan; 16(4):489-96. PubMed ID: 9484838 [TBL] [Abstract][Full Text] [Related]
3. Role of a truncated erythropoietin receptor for erythroid differentiation. Nakamura Y; Tokumoto Y; Nakauchi H Biochem Biophys Res Commun; 1996 Jan; 218(1):205-9. PubMed ID: 8573132 [TBL] [Abstract][Full Text] [Related]
4. Erythropoietin mediates terminal granulocytic differentiation of committed myeloid cells with ectopic erythropoietin receptor expression. Arcasoy MO; Maun NA; Perez L; Forget BG; Berliner N Eur J Haematol; 2001 Aug; 67(2):77-87. PubMed ID: 11722594 [TBL] [Abstract][Full Text] [Related]
5. Cooperation of Spi-1/PU.1 with an activated erythropoietin receptor inhibits apoptosis and Epo-dependent differentiation in primary erythroblasts and induces their Kit ligand-dependent proliferation. Quang CT; Wessely O; Pironin M; Beug H; Ghysdael J EMBO J; 1997 Sep; 16(18):5639-53. PubMed ID: 9312023 [TBL] [Abstract][Full Text] [Related]
6. Physician Education: The Erythropoietin Receptor and Signal Transduction. Yoshimura A; Arai K Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012 [TBL] [Abstract][Full Text] [Related]
7. Interleukin-10 inhibits RANKL-mediated expression of NFATc1 in part via suppression of c-Fos and c-Jun in RAW264.7 cells and mouse bone marrow cells. Mohamed SG; Sugiyama E; Shinoda K; Taki H; Hounoki H; Abdel-Aziz HO; Maruyama M; Kobayashi M; Ogawa H; Miyahara T Bone; 2007 Oct; 41(4):592-602. PubMed ID: 17627913 [TBL] [Abstract][Full Text] [Related]
8. Glioblastoma multiforme cells: expression of erythropoietin receptor and response to erythropoietin. Yin D; Kawabata H; Tcherniamtchouk O; Huynh T; Black KL; Koeffler HP Int J Oncol; 2007 Nov; 31(5):1193-8. PubMed ID: 17912447 [TBL] [Abstract][Full Text] [Related]
9. Reactive oxygen species generated by hematopoietic cytokines play roles in activation of receptor-mediated signaling and in cell cycle progression. Iiyama M; Kakihana K; Kurosu T; Miura O Cell Signal; 2006 Feb; 18(2):174-82. PubMed ID: 15982852 [TBL] [Abstract][Full Text] [Related]
10. Human erythropoietin receptor increases GATA-2 and Bcl-xL by a protein kinase C-dependent pathway in human erythropoietin-dependent cell line AS-E2. Tsushima H; Urata Y; Miyazaki Y; Fuchigami K; Kuriyama K; Kondo T; Tomonaga M Cell Growth Differ; 1997 Dec; 8(12):1317-28. PubMed ID: 9419420 [TBL] [Abstract][Full Text] [Related]
11. Erythropoietin receptor and interleukin-2 receptor use different downstream signaling pathways for proliferation and apoptosis-block. Yamamura Y; Noda M; Ikawa Y Leukemia; 1994 Apr; 8 Suppl 1():S107-10. PubMed ID: 8152274 [TBL] [Abstract][Full Text] [Related]
12. Kit signaling and negative regulation of daunorubicin-induced apoptosis: role of phospholipase Cgamma. Plo I; Lautier D; Casteran N; Dubreuil P; Arock M; Laurent G Oncogene; 2001 Oct; 20(46):6752-63. PubMed ID: 11709710 [TBL] [Abstract][Full Text] [Related]
13. Erythropoietin fails to interfere with the antiproliferative and cytotoxic effects of antitumor drugs. Gewirtz DA; Di X; Walker TD; Sawyer ST Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2232-8. PubMed ID: 16609039 [TBL] [Abstract][Full Text] [Related]
14. In vivo expansion of gene-modified hematopoietic cells by a novel selective amplifier gene utilizing the erythropoietin receptor as a molecular switch. Nagashima T; Ueda Y; Hanazono Y; Kume A; Shibata H; Ageyama N; Terao K; Ozawa K; Hasegawa M J Gene Med; 2004 Jan; 6(1):22-31. PubMed ID: 14716674 [TBL] [Abstract][Full Text] [Related]
15. A "classical" homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cells. Um M; Gross AW; Lodish HF Cell Signal; 2007 Mar; 19(3):634-45. PubMed ID: 17045782 [TBL] [Abstract][Full Text] [Related]
16. Activation and inhibition of the erythropoietin receptor by a membrane-anchored erythropoietin. Negre O; Fusil F; Henri A; Villette JM; Leboulch P; Beuzard Y; Payen E Exp Hematol; 2008 Apr; 36(4):412-23. PubMed ID: 18295963 [TBL] [Abstract][Full Text] [Related]
17. Induction of c-fos, c-jun, junB and junD mRNA and AP-1 by alkylating mutagens in cells deficient and proficient for the DNA repair protein O6-methylguanine-DNA methyltransferase (MGMT) and its relationship to cell death, mutation induction and chromosomal instability. Dosch J; Kaina B Oncogene; 1996 Nov; 13(9):1927-35. PubMed ID: 8934539 [TBL] [Abstract][Full Text] [Related]
18. Role of glutathione in the induction of apoptosis and c-fos and c-jun mRNAs by oxidative stress in tumor cells. Tormos C; Javier Chaves F; Garcia MJ; Garrido F; Jover R; O'Connor JE; Iradi A; Oltra A; Oliva MR; Sáez GT Cancer Lett; 2004 May; 208(1):103-13. PubMed ID: 15105052 [TBL] [Abstract][Full Text] [Related]
19. Apoptosis induced by hydrogen peroxide under serum deprivation and its inhibition by antisense c-jun in F-MEL cells. Kim YH; Takahashi M; Suzuki E; Niki E Biochem Biophys Res Commun; 2000 May; 271(3):747-52. PubMed ID: 10814534 [TBL] [Abstract][Full Text] [Related]
20. [Differentiation and maturation of erythroblasts]. Nakamura Y Rinsho Byori; 1998 May; 46(5):435-40. PubMed ID: 9627494 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]